Search research articles
Contact Us
Filters
Showing results (401-410 of 457) with videos related to
Page
of 46
Sort By:
Frontiers in Endocrinology
|
June 6, 2022
Hyperuricemia is Associated With 2- and 5-Year Adverse Outcomes in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention
Xiao-Fang Tang, Chen He, Pei Zhu, et al.
Coronary Artery Disease
|
December 10, 2009
Treatment of mild-moderate calcified coronary lesions with sirolimus-eluting stent: real world data from a single center
Jin-Qing Yuan, Jian-Jun Li, Xue-Wen Qin, et al.
Bioactive Materials
|
May 24, 2024
Long-term efficacy, safety and biocompatibility of a novel sirolimus eluting iron bioresorbable scaffold in a porcine model
Ya-Nan Gao, Hong-Tao Yang, Zi-Feng Qiu, et al.
Chinese Medical Journal
|
October 3, 2020
Clinical characteristics of early and late drug-eluting stent in-stent restenosis and mid-term prognosis after repeated percutaneous coronary intervention
Jian-Feng Zheng, Ting-Ting Guo, Yuan Tian, et al.
Chinese Medical Journal
|
January 23, 2008
Effects of sirolimus-eluting stent on calcified coronary lesions
Jian-jun Li, Bo Xu, Yue-jin Yang, et al.
Chinese Medical Journal
|
April 19, 2007
Age-based clinical and angiographic outcomes after sirolimus-eluting stent implantation in patients with coronary artery disease
Bo Xu, Jian-jun Li, Yue-jin Yang, et al.
Chinese Medical Journal
|
July 13, 2006
A comparison of angiographic and clinical outcomes after sirolimus-eluting versus paclitaxel-eluting stents for the treatment of in-stent restenosis
Jian-jun Li, Bo Xu, Yue-jin Yang, et al.
Chinese Medical Journal
|
April 27, 2011
A prospective multicenter parallel-controlled trial of TIVOLI biodegradable-polymer-based sirolimus-eluting stent compared to ENDEAVOR zotarolimus-eluting stent for the treatment of coronary artery disease: 8-month angiographic and 2-year clinical follow-up results
Bo Xu, Ke-fei Dou, Ya-ling Han, et al.
BMC Medicine
|
October 8, 2024
HLA diversity unveils susceptibility and organ-specific occurrence of second primary cancers: a prospective cohort study
Zi-Xuan Rong, Wei Wei, Qin Zeng, et al.
Zhonghua Xin Xue Guan Bing Za Zhi
|
June 1, 2005
[Coronary angiography by transradial approach with 5F universal catheter]
Rui Lu, Min Yao, Shu-bin Qiao, et al.
Page
of 46
Search research articles
Search
Showing results (401-410 of 457) with videos related to
Sort By:
Page
of 46
Frontiers in Endocrinology
|
June 6, 2022
Hyperuricemia is Associated With 2- and 5-Year Adverse Outcomes in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention
Xiao-Fang Tang, Chen He, Pei Zhu, et al.
Coronary Artery Disease
|
December 10, 2009
Treatment of mild-moderate calcified coronary lesions with sirolimus-eluting stent: real world data from a single center
Jin-Qing Yuan, Jian-Jun Li, Xue-Wen Qin, et al.
Bioactive Materials
|
May 24, 2024
Long-term efficacy, safety and biocompatibility of a novel sirolimus eluting iron bioresorbable scaffold in a porcine model
Ya-Nan Gao, Hong-Tao Yang, Zi-Feng Qiu, et al.
Chinese Medical Journal
|
October 3, 2020
Clinical characteristics of early and late drug-eluting stent in-stent restenosis and mid-term prognosis after repeated percutaneous coronary intervention
Jian-Feng Zheng, Ting-Ting Guo, Yuan Tian, et al.
Chinese Medical Journal
|
January 23, 2008
Effects of sirolimus-eluting stent on calcified coronary lesions
Jian-jun Li, Bo Xu, Yue-jin Yang, et al.
Chinese Medical Journal
|
April 19, 2007
Age-based clinical and angiographic outcomes after sirolimus-eluting stent implantation in patients with coronary artery disease
Bo Xu, Jian-jun Li, Yue-jin Yang, et al.
Chinese Medical Journal
|
July 13, 2006
A comparison of angiographic and clinical outcomes after sirolimus-eluting versus paclitaxel-eluting stents for the treatment of in-stent restenosis
Jian-jun Li, Bo Xu, Yue-jin Yang, et al.
Chinese Medical Journal
|
April 27, 2011
A prospective multicenter parallel-controlled trial of TIVOLI biodegradable-polymer-based sirolimus-eluting stent compared to ENDEAVOR zotarolimus-eluting stent for the treatment of coronary artery disease: 8-month angiographic and 2-year clinical follow-up results
Bo Xu, Ke-fei Dou, Ya-ling Han, et al.
BMC Medicine
|
October 8, 2024
HLA diversity unveils susceptibility and organ-specific occurrence of second primary cancers: a prospective cohort study
Zi-Xuan Rong, Wei Wei, Qin Zeng, et al.
Zhonghua Xin Xue Guan Bing Za Zhi
|
June 1, 2005
[Coronary angiography by transradial approach with 5F universal catheter]
Rui Lu, Min Yao, Shu-bin Qiao, et al.
Page
of 46